Cannara Biotech Inc. (LOVE.V)
Cannara Biotech Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Saint-Laurent, QC, CA. The stock last traded at $1.89, up 6.18% on the session, giving a market capitalisation of $181.0M. Its beta of 0.34 implies it has historically moved less than the broad market.
Cannara Biotech Inc., along with its various subsidiary entities, specializes in the indoor cultivation, processing, and commercialization of cannabis and its derivative products across Canada. The company also supplies hemp-derived CBD items via its online retail platform. This enterprise was established in 2017, with its primary corporate offices situated in Saint-Laurent, Canada.
Cannara Biotech Inc. is most often compared with the following Healthcare names: